Pharmacokinetics of oral voriconazole in patients with cystic fibrosis

J Antimicrob Chemother. 2011 Oct;66(10):2438-40. doi: 10.1093/jac/dkr300. Epub 2011 Jul 25.
No abstract available

Publication types

  • Clinical Trial, Phase IV
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / blood
  • Antifungal Agents / pharmacokinetics*
  • Aspergillosis / complications
  • Aspergillosis / drug therapy
  • Aspergillus fumigatus
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / metabolism*
  • Female
  • Humans
  • Male
  • Pyrimidines / administration & dosage
  • Pyrimidines / blood
  • Pyrimidines / pharmacokinetics*
  • Triazoles / administration & dosage
  • Triazoles / blood
  • Triazoles / pharmacokinetics*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole